PlainPharmaWatch

CMS Open Payments · Tool

Austin Medical Ventures Inc vs OCULUS, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Austin Medical Ventures Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 4,898, versus 1,529 for the other company. Its single largest recorded recipient represents 0.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Austin Medical Ventures Inc
HHI 4,898 · top recipient 0.5%
Ranked #378 of 1,838 companies by HHI
OCULUS, Inc.
HHI 1,529 · top recipient 0.3%
Ranked #853 of 1,838 companies by HHI

Payment Overview

Total Payments
$204.6K
% of Industry
0.0%
Transactions
11
Avg per Transaction
$18.6K
Recipients
11
Avg per Recipient
$18.6K
Payment Types
3
Top Payment Type
Royalty or License
Company B

OCULUS, Inc.

Total Payments
$204.0K
% of Industry
0.0%
Transactions
74
Avg per Transaction
$2.8K
Recipients
74
Avg per Recipient
$2.8K
Payment Types
6
Top Payment Type
Honoraria

Highlighted values indicate the higher figure for each metric.

Total payments compared

Austin Medical Ventures Inc vs OCULUS, Inc. - total reported payments in CMS Open Payments PY2024

Austin Medical Ventures Inc$204.6KOCULUS, Inc.$204.0K

Payment Types Breakdown

Austin Medical Ventures Inc

Royalty or License $202.5K

98.9%

Consulting Fee $2.1K

1.0%

Food and Beverage $29.73

0.0%

OCULUS, Inc.

Honoraria $84.9K

41.6%

Consulting Fee $50.0K

24.5%

Royalty or License $34.6K

17.0%

Compensation for Services Other Than Consulting $29.8K

14.6%

Travel and Lodging $3.3K

1.6%

Food and Beverage $1.4K

0.7%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Austin Medical Ventures Inc

  1. 1

    ANDREW WASSEF

    $103,265.74 · 4 txns

  2. 2

    EDWARD MCPHERSON

    $99,184.47 · 4 txns

  3. 3

    CHRISTOPHER GAULAND

    $1,680.00 · 1 txns

  4. 4

    PAUL MATUSZEWSKI

    $450.00 · 1 txns

  5. 5

    SCOTT PLASTER

    $29.73 · 1 txns

OCULUS, Inc.

  1. 1

    Crystal M. Brimer O.D.

    $54,400.00 · 5 txns

  2. 2

    Rolando Toyos M.D.

    $41,500.00 · 5 txns

  3. 3

    Jack T. Holladay M.D.

    $30,000.00 · 12 txns

  4. 4

    Marguerite B. McDonald M.D.

    $20,000.00 · 4 txns

  5. 5

    Paul M. Karpecki O.D.

    $13,500.00 · 3 txns

Summary Comparison

Metric Austin Medical Ventures Inc OCULUS, Inc.
Total Payments $204.6K $204.0K
% of Industry Total 0.0% 0.0%
Transaction Count 11 74
Avg per Transaction $18.6K $2.8K
Recipient Count 11 74
Avg per Recipient $18.6K $2.8K
Payment Type Count 3 6
Top Payment Type Royalty or License Honoraria

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.